AI-powered precision cardiovascular medicine for tomorrow's clinics
Cardiolpm combines deep learning with clinical expertise to redefine early detection, risk stratification, and personalized treatment pathways.
Seamlessly connected with leading medical device manufacturers and hospital networks.
Partnering with global healthcare leaders & academic medical centers
Next‑generation ECG interpretation
Our proprietary deep learning models detect over 95 distinct electrophysiological patterns covering 92% of common and rare arrhythmias, enabling early intervention and precision monitoring.
Explore the scienceWhy Cardiolpm leads the field
We are a health technology company focused on shifting cardiovascular care from reactive to proactive through ethically trained AI and real‑world data.
Our Vision
To eliminate preventable cardiac events globally by making AI‑driven cardiovascular insights accessible to every clinician and patient.
CE & FDA
Class IIa Medical Device Software
Cardiolpm Core Platform certified under EU MDR and FDA breakthrough designation.
Redefining clinical workflow efficiency
Cardiolpm Pulse is our cloud-native platform that helps cardiologists and primary care physicians triage critical cases, reduce reading time by 63%, and improve diagnostic confidence with AI‑powered insights.
Discover Pulse platformTailored solutions for the entire ecosystem
Cardiolpm powers cardiovascular intelligence across industries
Pharma & Biotech
Accelerate drug development with AI‑derived ECG endpoints, digital biomarkers, and decentralized trial support.
Health Systems
Reduce readmissions, optimize telemetry monitoring, and scale expert cardiology capacity with AI co‑pilot tools.
Clinical Research
Centralized cardiac safety monitoring, AI‑enhanced patient selection, and real‑time adverse event detection.
The first app where your heartbeat drives action.
Sync your wearables, understand your heart trends, and share actionable reports with your specialist — all in one secure place.
Get the app →
"Cardiolpm's AI platform transformed how we manage post‑surgical patients. The precision and early alerts give us a true safety net."
Dr. Elena Mendez
Chief of Cardiology, Madrid Institute of Heart & Vascular Health
One of the largest ECG databases globally
Our algorithms are trained on more than 12 million de‑identified ECGs spanning diverse geographies, ethnicities, and disease states — ensuring robust, equitable performance across populations.
Learn about our dataWhy clinicians trust Cardiolpm
⭐ 98% Sensitivity
For major arrhythmia detection in validation studies across 15 clinical sites.
⚡ 80% Faster Reads
Average reduction in ECG interpretation time for emergency departments.
🔒 HIPAA & GDPR
Enterprise‑grade security with end‑to‑end encryption and audit trails.
Latest insights
Cardiolpm in the news and peer‑reviewed publications
Research highlight
Cardiolpm algorithm shows 94% accuracy in predicting heart failure risk, study in JACC
Company milestone
Cardiolpm closes €24M Series B to expand AI cardiology platform across US and Europe
Strategic partnership
Cardiolpm partners with global CRO to integrate AI‑ECG in Phase III trials
Let's advance cardiac care together
Reach out to our team for demos, partnerships, or scientific collaboration
📍 Headquarters
🏢 Cardiolpm HQ, 30 Madison Avenue, Suite 1400, New York, NY 10017, USA
📞 +1 (212) 555‑8930
📧 contact@cardiolpm.com
📧 support@cardiolpm.com
🕒 Mon-Fri: 8:00 AM – 8:00 PM EST
👩💼 Leadership & Ownership
Dr. Sophia Laurent – CEO & Co‑founder
James O'Connor – Chief Technology Officer
Dr. Priya Kapoor – Chief Medical Officer
Cardiolpm is a privately held company backed by leading healthtech investors. For investor relations: ir@cardiolpm.com